DK1668368T3 - Detektion af histon-modifikation i cellefrie nukleosomer - Google Patents
Detektion af histon-modifikation i cellefrie nukleosomerInfo
- Publication number
- DK1668368T3 DK1668368T3 DK04768123T DK04768123T DK1668368T3 DK 1668368 T3 DK1668368 T3 DK 1668368T3 DK 04768123 T DK04768123 T DK 04768123T DK 04768123 T DK04768123 T DK 04768123T DK 1668368 T3 DK1668368 T3 DK 1668368T3
- Authority
- DK
- Denmark
- Prior art keywords
- cell
- free nucleosomes
- detection
- nucleosomes
- histone modification
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/70—Mechanisms involved in disease identification
- G01N2800/7023—(Hyper)proliferation
- G01N2800/7028—Cancer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Steroid Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
- Geophysics And Detection Of Objects (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0319376.0A GB0319376D0 (en) | 2003-08-18 | 2003-08-18 | Histone modification detection |
| PCT/GB2004/003564 WO2005019826A1 (en) | 2003-08-18 | 2004-08-18 | Detection of histone modification in cell-free nucleosomes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1668368T3 true DK1668368T3 (da) | 2009-02-23 |
Family
ID=28052702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04768123T DK1668368T3 (da) | 2003-08-18 | 2004-08-18 | Detektion af histon-modifikation i cellefrie nukleosomer |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US9128086B2 (es) |
| EP (1) | EP1668368B1 (es) |
| AT (1) | ATE411525T1 (es) |
| DE (1) | DE602004017201D1 (es) |
| DK (1) | DK1668368T3 (es) |
| ES (1) | ES2315697T3 (es) |
| GB (1) | GB0319376D0 (es) |
| SI (1) | SI1668368T1 (es) |
| WO (1) | WO2005019826A1 (es) |
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0319376D0 (en) * | 2003-08-18 | 2003-09-17 | Chroma Therapeutics Ltd | Histone modification detection |
| DE602006018458D1 (de) * | 2005-04-29 | 2011-01-05 | Univ California | Antikörper gegen histonmodifikationen für die klinische krebsdiagnose und -prognose |
| US8119572B2 (en) | 2005-10-24 | 2012-02-21 | Wisconsin Alumni Research Foundation | Methods for determining protein binding specificity using peptide libraries |
| US9035068B2 (en) | 2010-09-24 | 2015-05-19 | The Rockefeller University | Phosphohistidine analogs |
| GB201115095D0 (en) | 2011-09-01 | 2011-10-19 | Singapore Volition Pte Ltd | Method for detecting nucleosomes containing nucleotides |
| GB201115098D0 (en) | 2011-09-01 | 2011-10-19 | Belgian Volition Sa | Method for detecting nucleosomes containing histone variants |
| GB201115099D0 (en) | 2011-09-01 | 2011-10-19 | Belgian Volition Sa | Method for detecting nucleosomes |
| BR112014013082B1 (pt) | 2011-12-07 | 2021-02-02 | Singapore Volition Pte Limited | uso de um aduto nucleossomo-proteína e métodos para detectar a presença de um aduto nucleossomo-proteína |
| GB201303575D0 (en) * | 2013-02-28 | 2013-04-10 | Singapore Volition Pte Ltd | Method for detecting histone modifications in nucleosomes |
| GB201303576D0 (en) * | 2013-02-28 | 2013-04-10 | Singapore Volition Pte Ltd | Method for predicting therapy efficacy using nucleosome structure biomarkers |
| EP2775304A1 (en) * | 2013-03-07 | 2014-09-10 | Universitätsspital Basel | Methods for detecting inflammatory disorder |
| JP6721599B2 (ja) | 2014-10-29 | 2020-07-15 | ベルジアン ボリション エスピーアールエル | 循環する腫瘍ｄｎａの濃縮方法 |
| GB201518674D0 (en) * | 2015-10-21 | 2015-12-02 | Singapore Volition Pte Ltd | Method for detecting nuleosomes containing histone modifications and variants |
| GB201518665D0 (en) * | 2015-10-21 | 2015-12-02 | Singapore Volition Pte Ltd | Method for enrichment of cell free nucleosomes |
| EP3445782A4 (en) | 2016-04-20 | 2020-01-15 | Aelan Cell Technologies, Inc. | H1.0 DIMETHYLATED K180 PROTEIN COMPOSITIONS AND METHODS |
| TWI726009B (zh) * | 2016-11-28 | 2021-05-01 | 比利時商比利時意志有限公司 | 用親和純化法分析生物樣品中源自腫瘤之無細胞核小體、分離生物樣品中純化之腫瘤dna、檢測生物樣品中源自腫瘤之核小體表觀遺傳表位或在動物或人類受試者中檢測癌症之方法或包括組蛋白h1結合劑之套組之用途 |
| CN111433605B (zh) | 2017-09-18 | 2023-09-08 | 圣特萨斯股份公司 | 用于针对循环无细胞dna纯化血液的方法和装置 |
| CN111770761B (zh) | 2017-10-25 | 2024-07-09 | 爱兰细胞技术公司 | H1.0k180me2抗体、其制造方法和用途 |
| GB201721569D0 (en) | 2017-12-21 | 2018-02-07 | Belgian Volition Sprl | Method for the detection and treatment of colorectal adenomas |
| WO2019140082A1 (en) * | 2018-01-10 | 2019-07-18 | Epicypher, Inc. | Methods for quantification of nucleosome modifications and mutations at genomic loci and clinical applications thereof |
| CA3091807A1 (en) * | 2018-03-01 | 2019-09-06 | Epicypher, Inc. | Quantification of nucleosome modifications using chemically-defined recombinant nucleosomes |
| CN112119166A (zh) * | 2018-03-13 | 2020-12-22 | 耶路撒冷希伯来大学伊萨姆研发有限公司 | 无细胞dna染色质免疫沉淀的诊断应用 |
| CA3094717A1 (en) | 2018-04-02 | 2019-10-10 | Grail, Inc. | Methylation markers and targeted methylation probe panels |
| CN113286881A (zh) | 2018-09-27 | 2021-08-20 | 格里尔公司 | 甲基化标记和标靶甲基化探针板 |
| GB201818965D0 (en) | 2018-11-21 | 2019-01-09 | Belgian Volition Sprl | Method for the detection of colorectal cancer |
| GB201818963D0 (en) | 2018-11-21 | 2019-01-09 | Belgian Volition Sprl | Methof for the detection of prostate cancer |
| GB201906199D0 (en) | 2019-05-02 | 2019-06-19 | Belgian Volition Sprl | Method for the detection of cancer |
| GB201906201D0 (en) | 2019-05-02 | 2019-06-19 | Belgian Voltion Sprl | Method for the detection of protate cancer |
| AU2020336928A1 (en) | 2019-08-27 | 2022-03-24 | Belgian Volition Srl | Method of isolating circulating nucleosomes |
| GB201912251D0 (en) | 2019-08-27 | 2019-10-09 | Belgian Volition Sprl | Method of isolating circulating nucleosomes |
| MX2022006655A (es) | 2019-12-02 | 2022-09-07 | Belgian Volition Srl | Uso de nucleosomas libres de celulas como biomarcadores. |
| AU2021238782A1 (en) | 2020-03-20 | 2022-09-22 | Belgian Volition Srl | Triaging method using cell free nucleosome levels |
| EP4213909A1 (en) | 2020-09-21 | 2023-07-26 | Belgian Volition SRL | Device for inline monitoring of free nucleosomes in blood |
| EP4237850A4 (en) * | 2020-11-02 | 2024-09-18 | Epicypher Inc | IMPROVED ASSAYS FOR QUANTIFYING CHROMATIN TARGETS USING ANTIBODY-TARGETED ENZYMATIC DIGESTION |
| TW202238131A (zh) | 2020-11-25 | 2022-10-01 | 比利時商比利時意志有限公司 | 測量無細胞核蛋白染色質片段之方法 |
| TW202238132A (zh) | 2020-12-08 | 2022-10-01 | 比利時商比利時意志有限公司 | 多發性硬化症之診斷方法 |
| TW202242145A (zh) | 2020-12-29 | 2022-11-01 | 比利時商比利時意志有限公司 | 核小體耗盡循環無細胞染色質片段之轉錄因子結合位點分析 |
| TW202242130A (zh) | 2020-12-29 | 2022-11-01 | 比利時商比利時意志有限公司 | 循環轉錄因子分析 |
| TW202242146A (zh) | 2021-01-13 | 2022-11-01 | 比利時商比利時意志有限公司 | 肺癌的檢測方法 |
| GB202108185D0 (en) | 2021-06-08 | 2021-07-21 | Belgian Volition Sprl | Standardisation of nucleosome assays using biologically derived calibrants |
| GB202108452D0 (en) | 2021-06-14 | 2021-07-28 | Belgian Volition Sprl | Triaging method using cell free nucleosome levels |
| WO2023073179A1 (en) | 2021-10-29 | 2023-05-04 | Belgian Volition Srl | Homogeneous immunoassay method |
| GB202117799D0 (en) | 2021-12-09 | 2022-01-26 | Belgian Volition Srl | Method for the detection of blood cancer |
| US12053567B2 (en) | 2021-12-27 | 2024-08-06 | Santersus Ag | Method and device for removal of circulating cell free DNA |
| WO2023170298A1 (en) | 2022-03-11 | 2023-09-14 | Belgian Volition Srl | Differential diagnosis method |
| GB202205212D0 (en) | 2022-04-08 | 2022-05-25 | Belgian Volition Sprl | Method for transplant organ health assessment |
| WO2024042210A1 (en) | 2022-08-25 | 2024-02-29 | Belgian Volition Srl | Method for measuring cell free chromatin |
| WO2024042208A1 (en) | 2022-08-25 | 2024-02-29 | Belgian Volition Srl | Method for the detection of dementia |
| WO2024133225A1 (en) | 2022-12-19 | 2024-06-27 | Belgian Volition Srl | Calibration |
| WO2024133222A1 (en) | 2022-12-19 | 2024-06-27 | Belgian Volition Srl | Assessment of biological samples for nucleic acid analysis |
| GB202300607D0 (en) | 2023-01-16 | 2023-03-01 | Belgian Volition Srl | Proteins and methods for isolating circulating nucleosomes |
| GB202303562D0 (en) | 2023-03-10 | 2023-04-26 | Belgian Volition Sprl | Sample collection for liquid biopsy |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999047924A1 (en) | 1998-03-18 | 1999-09-23 | Roche Diagnostics Gmbh | Detection of apoptotic products |
| WO2003014142A2 (en) * | 2001-08-03 | 2003-02-20 | University Of Virginia Patent Foundation | Phosphorylated histone h2b as an apoptosis marker |
| RU2004116344A (ru) * | 2001-11-30 | 2005-03-27 | Пфайзер Продактс Инк. (Us) | Способы детекции клеток с аномалиями в числе хромосом |
| WO2003070894A2 (en) | 2002-02-20 | 2003-08-28 | University Of Virginia Patent Foundation | A non-invasive diagnostic test utilizing histone modification markers |
| US20060073517A1 (en) * | 2003-03-10 | 2006-04-06 | Allis C D | Post-translational modifications of proteins as regulatory switches |
| GB0319376D0 (en) | 2003-08-18 | 2003-09-17 | Chroma Therapeutics Ltd | Histone modification detection |
| DE602006018458D1 (de) * | 2005-04-29 | 2011-01-05 | Univ California | Antikörper gegen histonmodifikationen für die klinische krebsdiagnose und -prognose |
-
2003
- 2003-08-18 GB GBGB0319376.0A patent/GB0319376D0/en not_active Ceased
-
2004
- 2004-08-18 DK DK04768123T patent/DK1668368T3/da active
- 2004-08-18 ES ES04768123T patent/ES2315697T3/es not_active Expired - Lifetime
- 2004-08-18 WO PCT/GB2004/003564 patent/WO2005019826A1/en active Application Filing
- 2004-08-18 SI SI200430992T patent/SI1668368T1/sl unknown
- 2004-08-18 US US10/568,691 patent/US9128086B2/en active Active
- 2004-08-18 AT AT04768123T patent/ATE411525T1/de active
- 2004-08-18 DE DE602004017201T patent/DE602004017201D1/de not_active Expired - Lifetime
- 2004-08-18 EP EP04768123A patent/EP1668368B1/en not_active Expired - Lifetime
-
2015
- 2015-08-03 US US14/816,329 patent/US10408831B2/en not_active Expired - Lifetime
-
2019
- 2019-07-26 US US16/523,096 patent/US20190353653A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20190353653A1 (en) | 2019-11-21 |
| DE602004017201D1 (de) | 2008-11-27 |
| US10408831B2 (en) | 2019-09-10 |
| WO2005019826A1 (en) | 2005-03-03 |
| US20150330996A1 (en) | 2015-11-19 |
| ATE411525T1 (de) | 2008-10-15 |
| GB0319376D0 (en) | 2003-09-17 |
| EP1668368B1 (en) | 2008-10-15 |
| SI1668368T1 (sl) | 2009-04-30 |
| EP1668368A1 (en) | 2006-06-14 |
| US20070160989A1 (en) | 2007-07-12 |
| ES2315697T3 (es) | 2009-04-01 |
| US9128086B2 (en) | 2015-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1668368T3 (da) | Detektion af histon-modifikation i cellefrie nukleosomer | |
| MX2009004460A (es) | Inmunoensayo de analitos en muestras que contienen anticuerpos anti-analito endogenos. | |
| BRPI0618713B8 (pt) | cardiolipina modificada e seus usos | |
| ATE425266T1 (de) | Aptamer-nanopartikelkonjugate und verwendungsverfahren zur detektion von zielanalyten | |
| BRPI0610092B8 (pt) | métodos para a detecção de um analito e de um ácido nucleico em uma amostra, e de sintetização de uma molécula de ácido nucleico ou de análogo de ácido nucleico, kit reagente, uso do mesmo, molécula de ácido nucleico ou de análogo de ácido nucleico e produto associado | |
| DK2275815T3 (da) | Forbedrede immunoassay-fremgangsmåder | |
| WO2006026020A3 (en) | Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin | |
| ATE406578T1 (de) | Candida-nachweis | |
| ATE393914T1 (de) | Nachweis von biomolekülen unter verwendung poröser biosensoren und raman-spektroskopie | |
| FR2917174B1 (fr) | Analyse multiple d'echantillons sanguins | |
| DE602005001302D1 (de) | Bestimmung von analytcharakteristika auf der grundlage von bindungseigenschaften | |
| MA29730B1 (fr) | Detection d'un antigene cible independamment de la presence ou de l'absence d'un anticorps therapeutique correspondant | |
| WO2000043791A3 (en) | Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases | |
| DE602005014386D1 (de) | Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome | |
| WO2005114218A3 (en) | Cross-screening system and methods for detecting a molecule having binding affinity for a target molecule | |
| WO2002001230A3 (en) | Rapid and sensitive detection of protein aggregation | |
| GB2404022B (en) | Competitive assays for the detection of methamphetamine group drugs | |
| ATE503187T1 (de) | Nachweis eines therapeutischen antikörpers in einem versuchstier | |
| DE602007007775D1 (de) | Reagenz für hämoglobinabbau | |
| DE60331857D1 (de) | Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit | |
| WO2008060376A3 (en) | Algorithims for multivariant models to combine a panel of biomarkers for assessing the risk of developing ovarian cancer | |
| BRPI0416270A (pt) | método para detectar um analito em uma amostra, e, método e kit para detectar um anticorpo especìfico de uma amostra | |
| WO2005102938A3 (en) | Antibodies specific for bcr-abl fusion protein and uses thereof | |
| DE502006004301D1 (de) | Diagnose von allergischen erkrankungen, atopischen erkrankungen und/oder autoimmunerkrankungen durch nachweis von autoantikörpern gegen cd28 in humanem serum | |
| DE602004017317D1 (de) | Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome |